Last reviewed · How we verify

NCT06774612

The Impact of Large Language Models on Diagnostic Reasoning Among LLM-Trained Medical Doctors

Completed NA Last updated 17 July 2025
What this trial tests

NA trial testing ChatGPT-4o in Diagnosis in 60 participants. Completed in 17 May 2025.

Timeline
10 January 2025
Primary endpoint
17 May 2025
17 May 2025

Quick facts

Lead sponsorLahore University of Management Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment60
Start date10 January 2025
Primary completion17 May 2025
Estimated completion17 May 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Lahore University of Management Sciences

Who can join

Eligibility, any sex, with Diagnosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate whether large language model-trained medical doctors demonstrate enhanced diagnostic reasoning performance when utilizing ChatGPT-4o alongside conventional resources compared to using conventional resources alone.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. AI-literacy training enhances physician-LLM diagnostic collaboration in a resource-limited setting: a randomized controlled trial
    Qazi IA, Ali A, Khawaja AU, Akhtar MJ, et al · · 2025 · DOI 10.1101/2025.06.06.25329104

Verify or expand the search:

Other trials of ChatGPT-4o

Trials testing the same drug.

Other recruiting trials for Diagnosis

Currently open trials in the same condition.

Other Lahore University of Management Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06774612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing